ES2173633T3 - Polimero antitrombogeno marcado radiactivamente con 32p-polifosfaceno. - Google Patents

Polimero antitrombogeno marcado radiactivamente con 32p-polifosfaceno.

Info

Publication number
ES2173633T3
ES2173633T3 ES98952659T ES98952659T ES2173633T3 ES 2173633 T3 ES2173633 T3 ES 2173633T3 ES 98952659 T ES98952659 T ES 98952659T ES 98952659 T ES98952659 T ES 98952659T ES 2173633 T3 ES2173633 T3 ES 2173633T3
Authority
ES
Spain
Prior art keywords
polymer
polyphosphacene
antichrombogen
radioactive
antithrombogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98952659T
Other languages
English (en)
Inventor
Michael Grunze
Alexander Welle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universitaet Heidelberg
Original Assignee
Universitaet Heidelberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaet Heidelberg filed Critical Universitaet Heidelberg
Application granted granted Critical
Publication of ES2173633T3 publication Critical patent/ES2173633T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G79/00—Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule
    • C08G79/02—Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule a linkage containing phosphorus
    • C08G79/025—Polyphosphazenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/06—Use of macromolecular materials
    • A61L33/068—Use of macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0043—Catheters; Hollow probes characterised by structural features
    • A61M2025/0056—Catheters; Hollow probes characterised by structural features provided with an antibacterial agent, e.g. by coating, residing in the polymer matrix or releasing an agent out of a reservoir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0043—Catheters; Hollow probes characterised by structural features
    • A61M25/0045—Catheters; Hollow probes characterised by structural features multi-layered, e.g. coated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials For Medical Uses (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Polímero antitrombógeno que presenta la siguiente fórmula general (I), **fórmula** en la que n tiene un valor de 2 hasta 1, R 1 hasta R 6 son iguales o diferentes y significan un radical alcoxi, alquilsulfonilo, dialquilamino o ariloxi o un radical heterocicloalquilo o heteroarilo con nitrógeno como heteroátomo y en la que al menos una parte de la cadena polímera del polímero antitrombógeno contiene un constituyente marcado radiactivamente.
ES98952659T 1997-09-30 1998-09-29 Polimero antitrombogeno marcado radiactivamente con 32p-polifosfaceno. Expired - Lifetime ES2173633T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19743373A DE19743373A1 (de) 1997-09-30 1997-09-30 ·3··2·P-Polyphosphazen

Publications (1)

Publication Number Publication Date
ES2173633T3 true ES2173633T3 (es) 2002-10-16

Family

ID=7844268

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98952659T Expired - Lifetime ES2173633T3 (es) 1997-09-30 1998-09-29 Polimero antitrombogeno marcado radiactivamente con 32p-polifosfaceno.

Country Status (7)

Country Link
US (1) US20020054851A1 (es)
EP (1) EP1019102B1 (es)
AU (1) AU740470B2 (es)
DE (2) DE19743373A1 (es)
DK (1) DK1019102T3 (es)
ES (1) ES2173633T3 (es)
WO (1) WO1999016477A2 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208011B2 (en) 2001-08-20 2007-04-24 Conor Medsystems, Inc. Implantable medical device with drug filled holes
US7208010B2 (en) 2000-10-16 2007-04-24 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US6241762B1 (en) 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US20040254635A1 (en) 1998-03-30 2004-12-16 Shanley John F. Expandable medical device for delivery of beneficial agent
DE19855786A1 (de) * 1998-12-03 2000-06-08 Lothar Sellin Radioaktiver Carbon Stent
US6290673B1 (en) 1999-05-20 2001-09-18 Conor Medsystems, Inc. Expandable medical device delivery system and method
US6547816B1 (en) * 1999-07-12 2003-04-15 Civatech Corporation Formable integral source material for medical devices
CN1211130C (zh) * 2000-03-18 2005-07-20 保利詹尼克斯有限公司 具有抗菌性的聚磷腈衍生物及其应用
EP1274471B1 (de) * 2000-04-11 2007-01-03 Polyzenix GmbH Verwendung von Folien aus Poly-Tri-Fluor-Ethoxypolyphosphazenen zur Umhüllung von medizinischen Vorrichtungen
US20090004240A1 (en) * 2000-08-11 2009-01-01 Celonova Biosciences, Inc. Implants with a phosphazene-containing coating
EP1179353A1 (de) * 2000-08-11 2002-02-13 B. Braun Melsungen Ag Antithrombogene Implantate mit Beschichtung aus Polyphosphazenen und einem pharmakologisch aktiven Wirkstoff
PT1328213E (pt) 2000-10-16 2005-10-31 Conor Medsystems Inc Dispositivo medico expansivel para a administracao de um agente benefico
US9080146B2 (en) 2001-01-11 2015-07-14 Celonova Biosciences, Inc. Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface
DE10100961B4 (de) 2001-01-11 2005-08-04 Polyzenix Gmbh Körperverträglicher Werkstoff und mit diesem Werkstoff beschichtetes Substrat für die Züchtung von Zellen und künstlichen aus Zellen aufgebauten oder gewachsenen organischen Implantaten
DE10202467A1 (de) * 2002-01-23 2003-07-24 Polyzenix Gmbh Vorrichtung auf Basis von Nitinol, ein Verfahren zu dessen Herstellung sowie dessen Verwendung
US20040073294A1 (en) 2002-09-20 2004-04-15 Conor Medsystems, Inc. Method and apparatus for loading a beneficial agent into an expandable medical device
US6964680B2 (en) 2001-02-05 2005-11-15 Conor Medsystems, Inc. Expandable medical device with tapered hinge
DE10113971A1 (de) * 2001-03-22 2002-10-24 Polyzenix Gmbh Verfahren zur Beschichtung von Oberflächen aus Kunststoff mit Bis-Poly-Trifluorethoxy-Polyphosphazen und Derivaten
DK1432380T3 (da) 2001-08-17 2007-01-15 Polyzenix Gmbh Indretning baseret på nitrol med et overtræk af polyphosphazen
US7056338B2 (en) 2003-03-28 2006-06-06 Conor Medsystems, Inc. Therapeutic agent delivery device with controlled therapeutic agent release rates
EP1605983B1 (en) * 2003-03-26 2011-01-05 CeloNova BioSciences Germany GmbH Coated dental implants
US7169179B2 (en) 2003-06-05 2007-01-30 Conor Medsystems, Inc. Drug delivery device and method for bi-directional drug delivery
US7785653B2 (en) 2003-09-22 2010-08-31 Innovational Holdings Llc Method and apparatus for loading a beneficial agent into an expandable medical device
USD516723S1 (en) 2004-07-06 2006-03-07 Conor Medsystems, Inc. Stent wall structure
US9107850B2 (en) 2004-10-25 2015-08-18 Celonova Biosciences, Inc. Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
US9114162B2 (en) 2004-10-25 2015-08-25 Celonova Biosciences, Inc. Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
US20210299056A9 (en) 2004-10-25 2021-09-30 Varian Medical Systems, Inc. Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods
PT2089071E (pt) 2006-10-10 2012-03-09 Celonova Biosciences Inc Válvula cardíaca bioprotética com polifosfazeno
EP2254605A4 (en) * 2008-02-22 2012-06-20 Celonova Biosciences Inc MULTIFUNCTIONAL WOUND BRACING MATRICES AND RELEVANT PROCEDURES
EP3016688B1 (en) * 2013-07-01 2018-04-25 The Australian National University Radiolabelled material
CN110643046B (zh) * 2018-06-07 2021-04-02 北京化工大学 一种提高聚磷腈弹性体分子量和产率的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880622A (en) * 1986-05-20 1989-11-14 Research Corporation Technologies, Inc. Water-soluble phosphazene polymers having pharmacological applications
FR2655046B1 (fr) * 1989-11-24 1992-04-03 Centre Nat Rech Scient Composes oxodiaminodicyclophosphazenes de configuration mono-bino et di-bino, complexes derives de composes et applications desdits complexes et ces composes.
GB9407812D0 (en) * 1994-04-20 1994-06-15 Nycomed Salutar Inc Compounds
DE4428056A1 (de) * 1994-07-29 1996-02-08 Schering Ag Verwendung von Mikropartikelpräparationen zur Eliminierung gelöster, nicht nierengängiger Substanzen aus dem Blut
US5686113A (en) * 1995-03-21 1997-11-11 Temple University Of The Commonwealth System Of Higher Education Microcapsules of predetermined peptide(s) specificity (ies), their preparation and uses
DE19613048C2 (de) * 1995-03-30 1997-12-18 Michael Prof Dr Grunze Künstliche Implantate mit antithrombogenen Eigenschaften und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
WO1999016477A2 (de) 1999-04-08
US20020054851A1 (en) 2002-05-09
EP1019102A2 (de) 2000-07-19
DK1019102T3 (da) 2002-05-27
AU1027499A (en) 1999-04-23
EP1019102B1 (de) 2002-05-02
WO1999016477A3 (de) 1999-06-17
AU740470B2 (en) 2001-11-08
DE59803995D1 (en) 2002-06-06
DE19743373A1 (de) 1999-04-15

Similar Documents

Publication Publication Date Title
HN1996000017A (es) Isotiazolonas
ES2195970T3 (es) L-ribavirina y usos de la misma.
DE58903407D1 (de) Hubkolbenkompressor.
DE69010127D1 (de) Ausgleichskolben und Dichtungsanordnung.
EP0592202A3 (en) D-ketohexose-3-epimerase, and its manufacture and use.
FI912924L (fi) Laddade organiska polymermikropaerlor i pappersframstaellningsprocess.
DE59001649D1 (de) Hubkolbenkompressor.
DE68911644D1 (de) Schutzdiode gegen Überstrom.
FI905958A7 (fi) Foerfarande foer framstaellning av substituerade cyklohexanoler, som verkar pao det centrala nervsystemet.
ES2107033T3 (es) Peptidos bpc, su preparacion y su utilizacion.
ES2181056T3 (es) Composiciones para el control sistemico de parasitos de animales de sangre caliente.
DE68916614D1 (de) Kolbenschutzkappe.
DE69022957D1 (de) Spanner.
FI913737A0 (fi) Anordning foer montering av ett loephjul pao en drivaxel.
ES2154879T3 (es) Compuestos antiviricos.
DE69725459D1 (de) Substituierte 1,2,3,4-tetrahydro-2-dibenzofuranamine und 2-aminocyclohepta(b)benzofurane
IT9047587A1 (it) Componente semiconduttore di potenza, cellulare.
ES2155239T3 (es) Compuestos antiviricos.
FI883855A0 (fi) Foerfarande och koppling foer automatisk, pao en raeknare baserad reglering av frekvensen i en radiotelefon.
DE59000162D1 (de) Betaetigungshandhabe.
AR017436A1 (es) Una composicion farmaceutica en una dispersion molecular con biodisponibilidad mejorada
ITBZ920034A0 (it) Piattaforma mobile adibita al sollevamento di carichi.
IT9022118A0 (it) Fosfiti organici adatti come stabilizzanti e composizioni polimeriche comprendenti gli stessi.
FR2692321B1 (fr) Vérin pneumatique.
UY24915A1 (es) Derivados de benzoxazindiona, aplicación de los mismos y medicamentos que los contienen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 1019102

Country of ref document: ES